推荐产品
product name
U0126, U0126, CAS 109511-58-2, is a potent and specific inhibitor of MEK1 (IC₅₀ = 72 nM) and MEK2 (IC₅₀ = 58 nM). The inhibition is noncompetitive with respect to both ATP and ERK.
品質等級
化驗
≥98% (HPLC)
形狀
solid
製造商/商標名
Calbiochem®
儲存條件
OK to freeze
protect from light
顏色
white
溶解度
DMSO: 200 mg/mL
運輸包裝
ambient
儲存溫度
−20°C
InChI
1S/C18H16N6S2/c19-9-11(17(23)25-15-7-3-1-5-13(15)21)12(10-20)18(24)26-16-8-4-2-6-14(16)22/h1-8H,21-24H2/b17-11+,18-12+
InChI 密鑰
DVEXZJFMOKTQEZ-JYFOCSDGSA-N
一般說明
MEK1(IC50=72 nM)和MEK2(IC50=58 nM)的有效和特异性抑制剂。这种抑制对ATP和ERK都是非竞争性的。对其他激酶如Abl、Cdk2、Cdk4、ERK、JNK、MEKK、MKK-3、MKK-4/SEK、MKK-6、PKC和Raf几乎没有影响。显示可阻断多沙唑嗪诱导的成骨细胞分化。也可作为免疫抑制剂,有效阻断IL-2合成和T细胞增殖,而不影响T细胞活化或耐受的长期结果。对于ATP没有竞争性。也可提供InSolution格式(目录号662009)。
MEK1(IC50=72 nM)和MEK2(IC50=58 nM)的有效和特异性抑制剂。这种抑制对MEK底物、ATP和ERK是非竞争性的。对其他激酶如Abl、Cdk2、Cdk4、ERK、JNK、MEKK、MKK-3、MKK-4/SEK、MKK-6、PKC和Raf几乎没有影响。显示可阻断多沙唑嗪诱导的成骨细胞分化。U0126还可作为免疫抑制剂,有效阻断IL-2合成和T细胞增殖,而不影响T细胞活化或耐受的长期结果。对于ATP没有竞争性。也可提供InSolution格式(目录号662009。
生化/生理作用
主靶
MEK1和MEK2
MEK1和MEK2
产物不与ATP竞争。
可逆:否
细胞可渗透性:否
靶标IC50:针对MEK1和MEK2分别为72和58nM。
包裝
用惰性气体包装
警告
毒性:标准处理(A)
重構
溶液中不稳定;仅在使用前进行复溶。
其他說明
Choi, Y.J., et al. 2011.Biochem.Biophys.Res. Commun.416, 232.
DeSilva, D.R., et al. 1998.J. Immunol. 160, 4175.
Duncia, J.V., et al. 1998.Biorg.Med. Chem. Lett.8, 2839.
Favata, M.F., et al. 1998.J. Biol. Chem. 273, 18623.
DeSilva, D.R., et al. 1998.J. Immunol. 160, 4175.
Duncia, J.V., et al. 1998.Biorg.Med. Chem. Lett.8, 2839.
Favata, M.F., et al. 1998.J. Biol. Chem. 273, 18623.
法律資訊
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 2
閃點(°F)
Not applicable
閃點(°C)
Not applicable
Experimental neurobiology, 27(6), 489-507 (2019-01-15)
Survival and migration of transplanted neural stem cells (NSCs) are prerequisites for therapeutic benefits in spinal cord injury. We have shown that survival of NSC grafts declines after transplantation into the injured spinal cord, and that combining treadmill training (TMT)
Blockade of PD-L1/PD-1 signaling promotes osteo-/odontogenic differentiation through Ras activation.
International journal of oral science, 14(1), 18-18 (2022-04-03)
The programmed cell death ligand 1 (PD-L1) and its receptor programmed cell death 1 (PD-1) deliver inhibitory signals to regulate immunological tolerance during immune-mediated diseases. However, the role of PD-1 signaling and its blockade effect on human dental pulp stem
STAR protocols, 3(2), 101329-101329 (2022-04-29)
Intracerebroventricular (icv) injection of fibroblast growth factor 1 (FGF1) elicits remission of diabetic hyperglycemia in rodent models of type 2 diabetes. Here, we present an optimized protocol to study the intracellular signaling pathways underlying the FGF1-induced sustained glucose lowering in
Advanced science (Weinheim, Baden-Wurttemberg, Germany), 8(14), 2004973-2004973 (2021-07-27)
Regulatory T cells play a key role in immune tolerance to self-antigens, thereby preventing autoimmune diseases. However, no drugs targeting Treg cells have been approved for clinical trials yet. Here, a chimeric peptide is generated by conjugation of the cytoplasmic
Frontiers in cell and developmental biology, 9, 671244-671244 (2021-07-23)
MicroRNAs (miRNAs) are small non-coding RNAs which post-transcriptionally suppress target mRNAs expression and/or translation to modulate pathophyological processes. Expression and function of miRNAs are fine-tuned by a conserved biogenesis machinery involves two RNase-dependent processing steps of miRNA maturation and the
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门